19.12.2023
Milestone in the Fight Against Sleeping Sickness
The positive opinion by EMA is a major milestone after 30 years of research into better treatments for sleeping sickness. Photo: © Olivier Brandenberg/Swiss TPH)

Swiss TPH "The European Medicines Agency has adopted a positive opinion of fexinidazole for the treatment of T.b. rhodesiense sleeping sickness, found in Eastern and Southern Africa. The positive opinion is followed a clinical trial conducted by the HAT-r-ACC Consortium, of which Swiss TPH is a part. This is an important milestone in the fight against this acute and lethal form of the neglected tropical disease."